From Computational Biology Group
This section has been created in order to keep track of the conferences attended by the CBG members.
International Society of Computational Biology (ISCB) - Latin America 2012 - Santiago, Chile - March 17-21
- General info
The International Society for Computational Biology (ISCB) has held the ISCB Latin America Conference on Bioinformatics in Santiago, Chile, in March 17-21, 2012. This meeting constituted the second regional ISCB Latin America meeting, with the first held in Montevideo, Uruguay, in March 2010.
Conferences are key to the development and exchange of new ideas in science. Over the years many thousands of participants have attended ISCB’s annual ISMB conferences. As the majority of those attendees do their research in North America and Europe, the ISCB Regional Conferences aim to break the barrier imposed by high cost travel. How? By bringing a high quality conference, including lectures delivered by world-renowned scientists, to the regions of Latin America, Africa and Asia.
Toward this aim, in 2009 ISCB began organizing a newer series of smaller, regionally-based meetings as part of its mission to advance the science through world-wide education and training activities. These regional meetings have included ISCB-Africa (Mali 2009, South Africa 2011), ISCB-Latin America (Uruguay 2010) and ISCB-Asia (Malaysia 2011).
ISCB also aims to provide more students the opportunity to discuss and participate in the latest developments in bioinformatics and computational biology by bringing these meetings closer to home. We hope the ISCB-Latin America 2012 has been the second of many conferences that will contribute to the growth of the field within this region and support scientific innovation across Latin America.
More than 250 people attended, primarily from countries in Latin America.
The first two days of the meeting (March 17-18) were dedicated to hands-on practical tutorials and workshops covering different topics of interest.
The main conference took place March 19th-21st and featured the following six topic sessions (Each session had two keynote speakers and six oral presentations. There were also two poster sessions):
Session I. Comparative Genomics and Evolution
Session II. Genomics, Proteomics, Metagenomics and Metabolomics
Session III. Macromolecule Structure/Function Prediction
Session IV. Computer Aided Drug Design and Docking Simulations
Session V. Biomedicine and Immunoinformatics
Session VI. Functional Genomics and Systems Biology
- Selection of talks
Function prediction at different spatial scales", Peer Bork, EMBL, Heidelberg, Germany (www.bork.embl.de)"
- STITCH 3: zooming in on protein-chemical interactions,Kuhn M, Szklarczyk D, Franceschini A, von Mering C, Jensen LJ, Bork P, Nucleic Acids Res., 2012
To facilitate the study of interactions between proteins and chemicals, we have created STITCH, an aggregated database of interactions connecting over 300 000 chemicals and 2.6 million proteins from 1133 organisms. Compared to the previous version, the number of chemicals with interactions and the number of high-confidence interactions both increase 4-fold. The database can be accessed interactively through a web interface, displaying interactions in an integrated network view. It is also available for computational studies through downloadable files and an API. As an extension in the current version, we offer the option to switch between two levels of detail, namely whether stereoisomers of a given compound are shown as a merged entity or as separate entities. Separate display of stereoisomers is necessary, for example, for carbohydrates and chiral drugs. Combining the isomers increases the coverage, as interaction databases and publications found through text mining will often refer to compounds without specifying the stereoisomer. The database is accessible at http://stitch.embl.de/.
- Drug target identification using side-effect similarity.Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P, Science,2008
Targets for drugs have so far been predicted on the basis of molecular or cellular features, for example, by exploiting similarity in chemical structure or in activity across cell lines. We used phenotypic side-effect similarities to infer whether two drugs share a target. Applied to 746 marketed drugs, a network of 1018 side effect-driven drug-drug relations became apparent, 261 of which are formed by chemically dissimilar drugs from different therapeutic indications. We experimentally tested 20 of these unexpected drug-drug relations and validated 13 implied drug-target relations by in vitro binding assays, of which 11 reveal inhibition constants equal to less than 10 micromolar. Nine of these were tested and confirmed in cell assays, documenting the feasibility of using phenotypic information to infer molecular interactions and hinting at new uses of marketed drugs. "
- Enterotypes of the human gut microbiome, Arumugam M et al. ,Nature, 2011
Our knowledge of species and functional composition of the human gut microbiome is rapidly increasing, but it is still based on very few cohorts and little is known about variation across the world. By combining 22 newly sequenced faecal metagenomes of individuals from four countries with previously published data sets, here we identify three robust clusters (referred to as enterotypes hereafter) that are not nation or continent specific. We also confirmed the enterotypes in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not continuous. This indicates further the existence of a limited number of well-balanced host-microbial symbiotic states that might respond differently to diet and drug intake. The enterotypes are mostly driven by species composition, but abundant molecular functions are not necessarily provided by abundant species, highlighting the importance of a functional analysis to understand microbial communities. Although individual host properties such as body mass index, age, or gender cannot explain the observed enterotypes, data-driven marker genes or functional modules can be identified for each of these host properties. For example, twelve genes significantly correlate with age and three functional modules with the body mass index, hinting at a diagnostic potential of microbial markers.
my.microbes.eu: the study aims to provide new ways of analyzing any person's gut microbes in the context of samples from many individuals around the world. Visit the website if you wish to donate or participate.
"Using genomics to improve response to neoadjuvant therapy in patients with rectal cancer", Anamaría Camargo, Ludwig Institute for Cancer Research, Brazil
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing, Rebecca J. Leary et al., Sci. Transl. Med., 2010 -->idenfication of personalized biomarkers in rectal tumors
"Using 'omics' data to study regulator-target interactions and organizational principles in networks", Yves van de peer, University of Ghent, Belgium
"On the evolution of PPI networks", Sandro Jsé de Souza, Ludwig Institute for Cancer Research, Brazil
- Bioinformatics Training and Education in Iberoamerica